SlanDCs of untreated RRMS patients presented with higher levels of expression of IL-1beta, TNF-alpha as well as IL-12 and IL-23 compared to cells from FTY-treated patients (Table 2). Here, TNF is linked to relapsing-remitting multiple sclerosis.